Cathie L Linton

Title: Cathie L Linton: Innovator in Pharmaceutical Chemistry

Introduction

Cathie L Linton is a prominent inventor based in Waukegan, IL (US). She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 2 patents. Her work focuses on the development of innovative compounds that have potential therapeutic applications.

Latest Patents

Linton's latest patents include two crystalline compounds. The first patent is for a crystalline N-(4-(4-aminothieno[2,3-d]pyrimidin-5-yl)phenyl)-N'-(2-fluoro-5-(trifluoromethyl)phenyl)urea ethanolate. This compound is characterized in the monoclinic crystal system and P2/n space group, measured with radiation at 0.7107 Å. The lattice parameters are a, b, and c of 5.0318 Å ± 0.006 Å, 23.684 Å ± 0.002 Å, and 18.877 Å ± 0.002 Å, respectively, with β of 90.703 ± 0.003. The patent discloses methods of making the compound, compositions comprising it, and methods of treatment using it.

The second patent is for a crystalline N-(4-(4-aminothieno[2,3-d]pyrimidin-5-yl)phenyl)-N'-(2-fluoro-5-(trifluoromethyl)phenyl)urea benzenesulfonate. This compound is characterized in the triclinic crystal system and P-1 space group, also measured with radiation at 0.7107 Å. The lattice parameters are a, b, and c of 7.800 Å ± 0.001 Å, 13.406 Å ± 0.002 Å, and 13.554 Å ± 0.002 Å, respectively, with α, β, and γ of 67.155 ± 0.002, 79.724 ± 0.002°, and 84.067 ± 0.002, respectively. This patent also discloses methods of making the compound, compositions comprising it, and methods of treatment using it.

Career Highlights

Cathie L Linton is currently employed at Abbott Laboratories Corporation,